Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local delivery of CER-001 in advanced atherosclerotic plaques
2014-001666-10Phase 2Active
- Sponsor
- Amsterdam University Medical Center
- Start
- Jun 2014
- Modality
- Recombinant Proteins and Enzymes, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of CER-001 in atherosclerosis, sponsored by Amsterdam University Medical Center. Started Jun 2014; status: active.
02
Drugs
CER-001
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on 2014-001666-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001666-10.